Kramer Kelly A. bought GILD
November 26, 2025 · Form 4 insider transaction
Kramer Kelly A. bought 2,806 shares of Gilead Sciences, Inc. at $81.00 per share, a transaction worth $227.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,806
Price
$81.00
Total value
$227.3K
InsiderKramer Kelly A.
RoleDirector
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 26, 2025
Filing dateDecember 1, 2025
Shares owned after4,145
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025.